Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Lymphomas”

1,381 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,381 results

Not applicableStudy completedNCT00521430
What this trial is testing

Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more
Asan Medical Center 30
Not applicableEnded earlyNCT00161239
What this trial is testing

LAMPP Trial for Peripheral and Cutaneous T-Cell Lymphoma

Who this might be right for
T-Cell Lymphoma
University of Medicine and Dentistry of New Jersey 64
Testing effectiveness (Phase 2)Active Not RecruitingNCT06303167
What this trial is testing

Testing AZD9291 as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH-Subprotocol E)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)UnknownNCT03188198
What this trial is testing

Risk Adapted Therapy in Diffuse Large B Cell Lymphoma

Who this might be right for
Large B Cell Lymphoma
Mansoura University 60
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Early research (Phase 1)Ended earlyNCT00093704
What this trial is testing

Bortezomib and Ganciclovir in Treating Patients With Relapsed or Refractory Epstein Barr Virus-Positive Lymphoma

Who this might be right for
LymphomaLymphoproliferative Disorder
Jonsson Comprehensive Cancer Center 1
Early research (Phase 1)Active Not RecruitingNCT04447716
What this trial is testing

An Early Phase Study of Venetoclax, Lenalidomide, and Rituximab/Hyaluronidase in Slow-Growing Lymphomas That Have Come Back After Treatment or Have Not Responded to Treatment

Who this might be right for
Recurrent B-Cell Non-Hodgkin LymphomaRecurrent Follicular LymphomaRecurrent Indolent Adult Non-Hodgkin Lymphoma+5 more
Thomas Jefferson University 4
Not applicableStudy completedNCT02788916
What this trial is testing

A Retrospective Study of Clinical, Phenotypic and Genetic Factors of Peripheral T-Cell Lymphomas

Who this might be right for
Lymphoma, T-Cell, Peripheral
Takeda 198
Testing effectiveness (Phase 2)Study completedNCT01839916
What this trial is testing

Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+61 more
University of Chicago 77
Not applicableStudy completedNCT02434484
What this trial is testing

Symbenda Post-Marketing Surveillance (PMS)

Who this might be right for
Lymphoma, Non-HodgkinLymphocytic LeukemiaMultiple Myeloma
Eisai Korea Inc. 84
Testing effectiveness (Phase 2)Ended earlyNCT00785798
What this trial is testing

Vorinostat and Pegylated Liposomal Doxorubicin in Relapsed or Refractory Lymphomas

Who this might be right for
Relapsed LymphomasRefractory Lymphomas
Yale University 17
Large-scale testing (Phase 3)Study completedNCT00782145
What this trial is testing

A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+6 more
Tufts Medical Center 198
Testing effectiveness (Phase 2)Study completedNCT01153971
What this trial is testing

Induction and Maintenance Treatment With MabThera (Rituximab) in Patients With Indolent B-Cell Nonfollicular Lymphomas

Who this might be right for
Non-Hodgkin's Lymphoma
Hoffmann-La Roche 47
Early research (Phase 1)Ended earlyNCT00955292
What this trial is testing

Dose-escalation Study of Quarfloxin in Patients With Advanced Solid Tumors or Lymphomas

Who this might be right for
Advanced Solid TumorsLymphoma
Cylene Pharmaceuticals 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439279
What this trial is testing

Testing Trametinib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol R)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 35
Early research (Phase 1)Study completedNCT00006246
What this trial is testing

Busulfan in Treating Children and Adolescents With Refractory CNS Cancer

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorLeukemia+4 more
Pediatric Brain Tumor Consortium 28
Testing effectiveness (Phase 2)Study completedNCT00059995
What this trial is testing

MDX-060 Monoclonal Antibody in Treating Patients With Refractory or Relapsed Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)UnknownNCT05006664
What this trial is testing

Brentuximab Vedotin in Combination With CHEP in Patient With PTCL

Who this might be right for
Lymphoma, T-Cell, Peripheral
Czech Lymphoma Study Group 33
Not applicableLooking for participantsNCT06610344
What this trial is testing

BHB & CAR-T for Lymphomas

Who this might be right for
Large B-cell Lymphoma
Abramson Cancer Center at Penn Medicine 5
Not applicableStudy completedNCT02847130
What this trial is testing

Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology

Who this might be right for
Acute Lymphoblastic LeukemiaB-Cell Non-Hodgkin LymphomaChildhood Acute Myeloid Leukemia+5 more
Children's Oncology Group 530
Load More Results